Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 80
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00426127 | Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer | ||
| NCT00270894 | Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients | ||
| NCT00183794 | Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma | ||
| NCT00189449 | Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis | ||
| NCT00177255 | A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers | ||
| NCT01640782 | Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach | ||
| NCT00003257 | Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer | ||
| NCT00043576 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | ||
| NCT00193180 | Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer | ||
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | ||
| NCT00190411 | Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type | ||
| NCT00122564 | Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers | ||
| NCT00193050 | Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer | ||
| NCT00193427 | Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer | ||
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | ||
| NCT00176059 | Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients | ||
| NCT00256789 | Once Weekly Radiation for Lung Cancer With Chemotherapy | ||
| NCT00220064 | A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours | ||
| NCT00214058 | Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer | ||
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | ||
| NCT00186420 | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation | ||
| NCT00113347 | Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | ||
| NCT00211224 | Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS) | ||
| NCT00194558 | Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care | ||
| NCT00194740 | Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer | ||
| NCT00318890 | Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00215930 | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer | ||
| NCT00118131 | Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00257348 | Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer | ||
| NCT00087035 | Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer | ||
| NCT00121758 | AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers | ||
| NCT00280735 | Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC | ||
| NCT00221845 | Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients | ||
| NCT00216008 | Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. | ||
| NCT00002662 | Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer | ||
| NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | ||
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | ||
| NCT00090610 | Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer | ||
| NCT03004001 | Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome | ||
| NCT00193271 | Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer | ||
| NCT00193128 | Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer | ||
| NCT00193024 | Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer | ||
| NCT00268593 | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer | ||
| NCT00193115 | Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer | ||
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | ||
| NCT00148070 | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer | ||
| NCT00151073 | Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate | ||
| NCT00193037 | Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer | ||
| NCT00240747 | Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients | ||
| NCT00193232 | Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer |
